ENvue Medical, Inc.
FEED· OTC
Released Nov 14, 2022, after the close
10-Q filed Nov 14, 2022, 45 days after period end · 0001493152-22-032176
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Revenue | $97.00K | $499.00K | $150.00K | $101.00K |
| Net Income | -$955.00K | -$6.68M | -$922.00K | -$815.00K |
| EPS Diluted | -$0.68 |
ENvue Medical, Inc. · CIK 1326706 · Engraved from SEC EDGAR
| -$0.26 |
| -$0.10 |
| -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.